Home
Storia in 1 fonti
Biovica Granted Japanese Patent for Immuno-Oncology
UPPSALA, SE / ACCESS Newswire / July 1, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, specializing in blood-based cancer monitoring, today announced that the Japanese Patent Office has granted a new patent covering the use of TKa in relation to immune checkpoint inhibitor treatment in cancer patients.
Raccontata da
morningstar.com
Timeline cronologica
- ·
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
This release has been updated: MAR Tag Added UPPSALA, SE / ACCESS Newswire / June 30, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, specializing in…
- ·
Biovica Granted Japanese Patent for Immuno-Oncology
UPPSALA, SE / ACCESS Newswire / July 1, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, specializing in blood-based cancer monitoring, today…